Coherus Oncology
A Scientist, Quality Laboratory at Coherus is a senior quality-control laboratory professional focused on ensuring analytical quality and regulatory compliance for biologic drug substances and products. Based in Camarillo, CA, the role operates within the Quality Control organization and supports the lifecycle of analytical programs in a cGMP environment.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
2010
Coherus Oncology is a commercial-stage biopharmaceutical company focused on developing next‑generation combination therapies to improve outcomes for people living with cancer. The company advances novel combination regimens through clinical development and commercialization to address unmet needs across oncology. Coherus emphasizes scientific expertise, clinical rigor, and strategic partnerships to bring new therapeutic options to patients.
Coherus Oncology Pivots to Immuno-Oncology, Touts LOQTORZI Growth and New Pipeline at Citizens Conf.
2 days ago
Coherus Oncology: Q4 Earnings Snapshot
1 week ago
Coherus Oncology, Inc. to Release 2025 Financial Results on March 9, 2026, with Conference Call to Follow
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Coherus Oncology.
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
4 weeks ago